Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias

BACKGROUND: Targeted anticancer therapies such as BCR-ABL tyrosine kinase inhibitors (TKIs) have improved outcomes for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). However, little is known about long-term risks of TKIs in children. Expo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Smith, Stephanie M., Sabnis, Himalee S., Lewis, Rebecca Williamson, Effinger, Karen E., Bergsagel, John, Patterson, Briana, Mertens, Ann, Sakamoto, Kathleen M., Schapira, Lidia, Castellino, Sharon M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082962/
https://ncbi.nlm.nih.gov/pubmed/33926411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08182-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados